Biotech · Public company · San Antonio, TX, US

bioAffinity Technologies, Inc.

Ticker BIAF · SEC CIK 0001712762

Track this companyFree. Adds bioAffinity Technologies, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials42 recruiting or active

Pipeline programs1From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline1

Standard medical treatmentLung Cancer (Diagnosis)ClinicalTrials.gov · fetched Nov 12, 2026

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.NA · RECRUITING · started Feb 25, 2026ClinicalTrials.gov NCT07168993 · fetched Nov 12, 2026
Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung AssayUNKNOWN · started Aug 1, 2023ClinicalTrials.gov NCT05870592 · fetched Nov 12, 2026
Collection of Sputum and Labeling for Lung CancerRECRUITING · started Mar 1, 2018ClinicalTrials.gov NCT03457415 · fetched Nov 12, 2026
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung CancerCOMPLETED · started Sep 22, 2016ClinicalTrials.gov NCT03837600 · fetched Nov 12, 2026